Latest broker research reports with buy, sell, hold recommendations along with forecast target prices and upside. Browse thousands of reports and search by company or the broker.
|Summary||Date||Stock||Broker||Price at Reco.||Target||Price at reco|
Change since reco(%)
|2016-05-30||Anuh Pharma Ltd.||Motilal Oswal||202.75||240.00||202.75 (5.50%)||Target met||Buy|
In its bid to add new high value products, Anuh has been developing new APIs which have recently gone off patent (post 2014 or which are likely to go off patent in the future). These new APIs will have much higher margins compared to the existing basket. Anuh currently has 20 products in the pipeline of which 4 would be launched in...